Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Anika Therapeutics Inc. (ANIK) had Normalized Pre-Tax Income of $-3.97M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$28.22M |
|
$-3.97M |
|
$13.86M |
|
$14.36M |
|
$32.40M |
|
$-4.18M |
|
$0.21M |
|
$-3.97M |
|
|
Normalized Pre-Tax Income |
$-3.97M |
$-4.65M |
|
$-4.65M |
|
$-3.97M |
|
$-4.65M |
|
$-4.18M |
|
$-2.76M |
|
14.36M |
|
14.52M |
|
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$99.32M |
|
$41.08M |
|
$88.36M |
|
$187.68M |
|
$16.08M |
|
-- |
|
$23.93M |
|
$40.01M |
|
$147.67M |
|
$137.96M |
|
$147.67M |
|
14.42M |
|
| Cash Flow Statement Financials | |
$-0.32M |
|
$1.13M |
|
$-5.26M |
|
$57.16M |
|
$53.17M |
|
$-3.99M |
|
$5.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.18 |
|
-- |
|
-- |
|
-- |
|
-- |
|
50.90% |
|
-14.81% |
|
-14.81% |
|
-- |
|
-14.05% |
|
-14.07% |
|
$-4.01M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.82 |
|
1.18 |
|
76.40 |
|
-3.15% |
|
-3.37% |
|
-2.48% |
|
-3.15% |
|
$10.24 |
|
$-0.28 |
|
$-0.02 |
|